GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy

Adjuvant oxaliplatin-based chemotherapy is widely used for stage III colorectal cancer (CRC) after curative surgery. CRC is a molecularly heterogeneous disease, and our current knowledge of therapeutic response-related genetic factors remains limited. N-acetylgalactosaminyltransferase 14 (GALNT14)-r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Lin, Wey-Ran, Chiang, Jy-Ming, Liang, Kung-Hao, Lim, Siew-Na, Lai, Ming-Wei, Tsou, Yung-Kuan, Hsieh, Tzu-Yun, Hsu, Chih-Kai, Yeh, Chau-Ting
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2016
Assuntos:
3500
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998711/
https://ncbi.nlm.nih.gov/pubmed/27124048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados